A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(66 sites)

United States

San Jose Clinical Trials- Site Number : 8400016, San Jose, California

Solace Clinical Research - Tustin- Site Number : 8400020, Tustin, California

Life Clinical Trials - Margate - Colonial Drive- Site Number : 8400002, Margate, Florida

Schiff Center for Liver Diseases/University of Miami- Site Number : 8400010, Miami, Florida

Vitalia Medical Research - Margate- Site Number : 8400025, Palm Beach Gardens, Florida